Dermata Therapeutics Inc
Research Dermata Therapeutics Inc (DRMA) on Bullrun: market cap USD 6.92M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDRMA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 6.92M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 7.10M
- Free cash flow-USD 8.30M
Valuation Snapshot
latest market cap is USD 6.92M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 7.56M | -USD 7.76M | n/a | -8.16 | USD 7.52M | n/a | USD 6.22M |
| FY2024 | USD 0 | -USD 12.29M | -USD 11.16M | n/a | -80.32 | USD 3.16M | n/a | USD 1.56M |
| FY2023 | n/a | -USD 7.79M | n/a | n/a | -39.99 | USD 7.44M | n/a | USD 6.36M |
| FY2022 | n/a | -USD 9.61M | n/a | n/a | n/a | USD 6.24M | n/a | USD 6.02M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 6.92M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 6.17M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.40M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.16M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 5.01M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 14.62M | n/a | n/a | n/a |
About Dermata Therapeutics Inc
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dermata Therapeutics Inc's market cap?
Dermata Therapeutics Inc's market capitalization is USD 6.92M.
What does Dermata Therapeutics Inc do?
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.